Abstract:Potential conflict of interest: Nothing to report. To the Editor: We read with great interest the article by Bessho et al., who demonstrated that, among the 15 genes uniquely expressed in the liver of patients with biliary atresia (BA), IL8 and LAMC2 were sufficient to distinguish subjects with BA from patients with non‐BA controls, with an accuracy of 95%.1 They conclude that hepatic expression of these two genes may serve as a biomarker of disease. Whereas we appreciate the findings, we would like to address a few issues that may help further clarify or confirm the findings. First, only 14 patients were included as non‐BA controls; the causes of disease were unknown for 64.3% (n = 9) (Supporting Table 1 of Bessho et al.). Moreover, 21.4% (n = 3) of the non‐BA controls were misclassified by IL8 and LAMC2 as BA (Supporting Table 2 of Bessho et al.). It is conceivable that some non‐BA diseases share a similar genetic signature or phenotypic traits with BA, and exhibit similar hepatic expression profiles. Indeed, as previously demonstrated, the IL‐8 level is higher in the BA and non‐BA groups than in normal controls, and the increased IL‐8 level is associated with the lymphocytic count and the degree of fibrosis in BA.2 Also, it has been known that viral infection can promote IL‐8 expression in the liver, which is associated with chronic liver disease.5 Thus, subjects with virus infection in the non‐BA groups might have a similar level of hepatic IL‐8 expression, compared with those in the BA group. In the present study, whether the false positivity by IL8 and LAMC2 observed in three patients in the non‐BA group was associated with infections with viruses such as rotavirus, cytomegalovirus, etc. is unknown. Second, it has been reported that IL‐8 mRNA increases in the liver, particularly in the late stage of BA (e.g., the degree of fibrosis represented by aspartate aminotransferase‐to‐platelet ratio index) and advanced age, and is associated with persistent jaundice, portal hypertension, and/or an increased inflammation and fibrosis in the liver.3 Thus, it is recommended that the patients included in the study be divided into different groups according to the degree of fibrosis (e.g., aspartate aminotransferase‐to‐platelet ratio index) and age (e.g., ≤60, 61‐90, and > 90days). Therefore, it would be interesting if Bessho et al. were to reassess their data by taking viral infection, the degree of fibrosis, and age into account. Alternatively, a larger case‐controlled study incorporating the above‐mentioned points is required.

Hepatocellular telomere length in biliary atresia measured by Q-FISH

The Aberrant Expression of HLA-DR in Intrahepatic Bile Ducts in Patients with Biliary Atresia: an Immunohistochemistry and Immune Electron Microscopy Study.

Liver mitochondrial morphology and gene expression as markers of liver reserve: Prognostic implications for native liver survival in biliary atresia.

Liver transplantation for biliary atresia: A nationwide investigation from 1996 to 2013 in mainland China.

Long-term follow-up of biliary atresia using liver transient elastography

Bile lakes in patients with biliary atresia who presented with jaundice-free native liver survival indicating the risk of subsequent liver transplantation due to various factors

Telomere Length Variation in Tumor Cells and Cancer-Associated Fibroblasts: Potential Biomarker for Hepatocellular Carcinoma.

Telomere length of gallbladder epithelium is shortened in patients with congenital biliary dilatation: measurement by quantitative fluorescence in situ hybridization

Correlation between hepatic oxidative damage and clinical severity and mitochondrial gene sequencing results in biliary atresia.

Long-term outcomes of liver transplantation for biliary atresia and results of policy changes: over 20 years of follow-up experience

Carbon Flow Conversion Induces Alkali Resistance and Lipid Accumulation under Alkaline Conditions Based on Transcriptome Analysis in Chlorella Sp. BLD.

Liver disease and transplantation in telomere biology disorders: An international multicenter cohort

Bile acid profiles in adult patients with biliary atresia who achieve native liver survival after portoenterostomy

Paired Assessment of Liver Telomere Lengths in Hepatocellular Cancer is a Reliable Predictor of Disease Persistence

Biliary Atresia and Neonatal Cholestasis

Hepatic Expression of Interleukin 8 in Diagnosing Biliary Atresia

Biliary atresia and liver transplantation in the United States: A contemporary analysis

Living donor liver transplantations for pediatric patients withbiliary atresia in a single center: 306

Association of telomere length in peripheral leukocytes with chronic hepatitis B and hepatocellular carcinoma

Subclinical cardiac abnormalities in children with biliary atresia correlate with outcomes after liver transplantation

Genome-Wide Association Study Identifies A Susceptibility Locus for Biliary Atresia on 10Q24.2